Education
About Us
Working with TipRanks
Follow Us
Cellebrite DI (CLBT)
NASDAQ:CLBT
CLBT Stock Chart & Stats
Day’s Range― - ―
52-Week Range$10.25 - $26.30
Previous CloseN/A
Volume262.11K
Average Volume (3M)1.13M
Market Cap
$4.08B
Enterprise ValueN/A
Total Cash (Recent Filing)$447.22M
Total Debt (Recent Filing)$10.97M
Price to Earnings (P/E)―
Beta1.03
Next Earnings
Aug 06, 2025EPS Estimate
0.08Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.07
Shares Outstanding239,470,060
10 Day Avg. Volume1,640,937
30 Day Avg. Volume1,129,033
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$25.00Price Target Upside46.89% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering7
---
Cellebrite DI News
PremiumCompany Announcements
Cellebrite’s Earnings Call Highlights Growth Amid ChallengesPremiumCompany Announcements
Cellebrite Reports Strong Q1 2025 Financial Growth---
Bulls Say, Bears Say
Bulls Say
AI FeaturesAI and generative AI features help improve the competitiveness of Cellebrite's products.
Federal PipelineManagement provided positive commentary that the federal pipeline is improving.
PartnershipsPartnership with Relativity helps drive potential enterprise market opportunities.
Bears Say
EMEA PerformanceThe modest shortfall in U.S. Federal was compounded by a weaker-than-expected showing from the EMEA region.
Revenue GuidanceThe company lowered its full-year revenue guidance but reiterated its EBITDA guidance.
U.S. Federal DealsCellebrite issued second-quarter guidance below consensus, citing delays in closing U.S. federal deals related to the administration change and the budget continuing resolution.
---
Ownership Overview
―
Insiders
3.93% Mutual Funds
25.35% Other Institutional Investors
69.81% Public Companies and Individual Investors
CLBT FAQ
What was Cellebrite DI’s price range in the past 12 months?
Cellebrite DI lowest stock price was $10.24 and its highest was $26.30 in the past 12 months.
What is Cellebrite DI’s market cap?
Cellebrite DI’s market cap is $4.08B.
When is Cellebrite DI’s upcoming earnings report date?
Cellebrite DI’s upcoming earnings report date is Aug 06, 2025 which is in 77 days.
How were Cellebrite DI’s earnings last quarter?
Cellebrite DI released its earnings results on May 14, 2025. The company reported $0.07 earnings per share for the quarter, beating the consensus estimate of $0.053 by $0.017.
Is Cellebrite DI overvalued?
According to Wall Street analysts Cellebrite DI’s price is currently Undervalued.
Does Cellebrite DI pay dividends?
Cellebrite DI does not currently pay dividends.
What is Cellebrite DI’s EPS estimate?
Cellebrite DI’s EPS estimate is 0.08.
How many shares outstanding does Cellebrite DI have?
Cellebrite DI has 239,470,060 shares outstanding.
What happened to Cellebrite DI’s price movement after its last earnings report?
Cellebrite DI reported an EPS of $0.07 in its last earnings report, beating expectations of $0.053. Following the earnings report the stock price went down -11.481%.
Which hedge fund is a major shareholder of Cellebrite DI?
Currently, no hedge funds are holding shares in CLBT
---
Cellebrite DI Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$25.00 (46.89% Upside)
$25.00 (46.89% Upside)
Blogger Sentiment
Bullish
CLBT Sentiment 66%
Sector Average 68%
Sector Average 68%
Hedge Fund Trend
Decreased
By 445.7K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 8.1%
Last 30 Days ▲ 13.0%
Last 30 Days ▲ 13.0%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
44.61%
12-Months-Change
Fundamentals
Return on Equity
-115.35%
Trailing 12-Months
Asset Growth
34.16%
Trailing 12-Months
Company Description
Cellebrite DI
Cellebrite DI (CLBT) is a leading provider of digital intelligence solutions, catering primarily to the law enforcement, government, and enterprise sectors. The company specializes in providing tools and services designed to accelerate investigations and enhance decision-making processes through the extraction, analysis, and management of digital data from various devices. With a focus on digital forensics, Cellebrite's core products include advanced software and hardware solutions for data collection, analysis, and reporting.
---
CLBT Company Deck
---
CLBT Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
Cellebrite showed strong growth in several key areas, including ARR and specific product lines like Guardian, and hosted successful events and product releases. However, challenges in the U.S. Federal and EMEA markets moderated some of the positive impacts. Despite these challenges, the company remains optimistic about future growth, particularly in the second half of the year.Read More>---
CLBT Stock 12 Month Forecast
Average Price Target
$25.00
▲(46.89% Upside)
Technical Analysis
---